Avaleht › Rasvumine › Texas › Houston
Rasvumine kliinilised uuringud linnas Houston, TX
43 uuringut haiguse Rasvumine jaoks otsivad osalejaid linnas Houston ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.
Ametlik uuringutekst (inglise keeles)
Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
VärbamineFaas 2
- Juno Research /ID# 282413, Houston
- PlanIt Research /ID# 282204, Houston
- JCCT - Juno Bellaire /ID# 282263, Bellaire · 7 mi kaugusel
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
VärbamineFaas 2
- Cardiovascular Specialists of Willowbrook, Houston
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
VärbamineFaas 3
- PlanIt Research, PLLC, Houston
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
VärbamineFaas 3
- DM Clinical, Houston
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
VärbamineFaas 3
- Houston Research Institute, Houston
- The Endocrine Center, Houston
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
VärbamineFaas 3
- PlanIt Research, LLC (Monitoring Room), Houston
- PlanIt Research, LLC, Houston
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
VärbamineFaas 3
- Research Site, Houston
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
VärbamineFaas 3
- McGovern Medical School, Houston
- Texas Childrens Hospital, Houston
- Dynamed Clinical Research, LP d/b/a DM Clinical Research, Houston
- ja veel 1
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
VärbamineFaas 3
- Juno Research, Houston
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
VärbamineFaas 3
- Juno Research, Houston
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
VärbamineFaas 3
- Research Site, Houston
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
VärbamineFaas 3
- Biopharma Informatic, LLC, Houston
- Cardiovascular Specialists of Willowbrook, Houston
- PlanIt Research, PLLC, Houston
- ja veel 2
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
VärbamineFaas 3
- The University of Texas Health Science Center at Houston, Bellaire · 7 mi kaugusel
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
VärbamineFaas 3
- Care Access - Houston, Houston
- JCCT - Juno Bellaire Site, Bellaire · 7 mi kaugusel
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
VärbamineFaas 2
- PlanIt Research, PLLC, Houston
Semaglutide for Post-Smoking Cessation Weight Management
VärbamineFaas 2Terved vabatahtlikud oodatud
- The University of Texas Health Science Center at Houston, Houston
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
VärbamineFaas 3
- AURORA-2 Clinical Site, Houston
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
VärbamineFaas 3
- East Texas Cardiology PA, Houston
- Biopharma Informatic, Houston
- Orion Medical, Houston
- ja veel 3
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
VärbamineFaas 3
- HRI ? Medical Center, LLC, Houston
- Juno Research, LLC, Houston
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
VärbamineFaas 2
- Juno Research, Houston
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
VärbamineFaas 3
- Elevate Clinical, Houston
- Houston Research Institute, Houston
- Bellaire Clinical Research, LLC, Bellaire · 7 mi kaugusel
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
VärbamineFaas 3
- Houston Pulm Med Res Network, Houston
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
VärbamineFaas 3Terved vabatahtlikud oodatud
- ACCOMPLISH-2 Research Site, Houston
- ACCOMPLISH-2 Research Site, Houston
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
VärbamineFaas 3
- Houston Pulm Med Res Network, Houston
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
VärbamineFaas 2
- PlanIt Research, PLLC, Houston
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
VärbamineFaas 2
- Biopharma Informatic, LLC, Houston
- PlanIt Research, PLLC, Houston
- Research Physicians Network, LLC, Houston
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
VärbamineFaas 4
- Center for Clinical Studies, Houston
- Bellaire Dermatology Associates, Bellaire · 7 mi kaugusel
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
VärbamineFaas 3
- JCCT- Juno Northwest Houston, Houston
- Biopharma Informatic, LLC, Houston
- Johnson County Clinical Trials Juno Bellaire, Bellaire · 7 mi kaugusel
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
VärbamineFaas 3
- Kailera Clinical Site, Bellaire · 7 mi kaugusel
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
VärbamineFaas 3
- JCCT- Juno Northwest Houston, Houston
- Johnson County Clinical Trials Juno Bellaire, Bellaire · 7 mi kaugusel
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
VärbamineFaas 3
- Biopharma Informatic, LLC, Houston
- Research Physicians Network, LLC, Houston
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
VärbamineFaas 3
- Research Site, Houston
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
VärbamineFaas 2
- Baylor Texas Children's Hospital, Houston
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
VärbamineFaas 3
- East Texas Cardiology PA, Houston
- Victorium Clinical Research, Houston
- Main Heart Clinic, Houston
- ja veel 1
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
VärbamineFaas 3
- ACCOMPLISH-1 Research Site, Houston
- ACCOMPLISH-1 Research Site, Houston
PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents
VärbamineTerved vabatahtlikud oodatud
- Children's Nutrition Research Center, Houston
Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents
VärbamineTerved vabatahtlikud oodatudOsalejatele makstakse tasu
- USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine, Houston
Determinants of Insulin Sensitivity by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
- Lilli Health, Houston
Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery
Värbamine
- M D Anderson Cancer Center, Houston
Incretin Microdosing for Cardiometabolic Health in People With HIV
VärbamineFaas 2
- The University of Texas Health Science Center at Houston, Houston
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
VärbamineFaas 2
- Baylor College of Medicine, Houston
RESET System Pivotal Trial (Rev F)
Värbamine
- Baylor College of Medicine, Houston
Endoscopic Sleeve Gastroplasty (ESG) for the Treatment of Obesity
Värbamine
- Houston Methodist Hospital, Houston
Rasvumine uuringud teistes linnades
- Chicago, IL41 uuringut
- New York City, NY40 uuringut
- San Antonio, TX40 uuringut
- Washington, DC33 uuringut
- Orlando, FL31 uuringut
- Dallas, TX30 uuringut
- Boston, MA28 uuringut
- Las Vegas, NV27 uuringut
- Miami, FL27 uuringut
- Baltimore, MD25 uuringut
- Jacksonville, FL25 uuringut
- St. Louis, MO25 uuringut
Muud uuringud linnas Houston
- Mitteväikerakuline kopsuvähk145 uuringut
- Rinnavähk126 uuringut
- Vähk (kõik liigid)121 uuringut
- Metastaatiline vähk104 uuringut
- Käär- ja pärasoolevähk102 uuringut
- Munasarjavähk89 uuringut
- Äge müeloidne leukeemia85 uuringut
- Kopsuvähk78 uuringut
- Eesnäärmevähk76 uuringut
- Endomeetriumivähk68 uuringut
- Pankreasevähk61 uuringut
- Melanoom59 uuringut
Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.